Enliven Therapeutics所有资讯

Enliven Therapeutics | 144：拟议出售证券

11/16 05:39

Enliven Therapeutics | 144：拟议出售证券

11/16 05:33

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(2.2%),Peter Kolchinsky(2.2%)等

11/15 06:53

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(8.5%),VHCP Co-Investment Holdings III, LLC(8.5%)等

11/15 06:51

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Citadel Advisors LLC(3.7%),Citadel Advisors Holdings LP(3.7%)等

11/15 05:29

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%)等

11/15 05:23

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Commodore Capital LP(8.7%),Commodore Capital Master LP(8.7%)

11/15 05:15

Enliven Therapeutics | SC 13G：超过5%持股股东披露文件-Polar Capital Holdings Plc(5.69%),Polar Capital LLP(5.69%)

11/14 06:57

Enliven Therapeutics | 10-Q：2024财年三季报

11/14 05:20

Enliven Therapeutics | 8-K：Enliven Therapeutics公布第三季度财务业绩并提供业务最新情况

11/14 05:16

Enliven Therapeutics | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(6.2%)

11/09 03:26

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

10/31 06:07

Enliven Therapeutics | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(6.2%)

10/25 02:05

Enliven Therapeutics | 4：持股变动声明-高管 Patel Anish

10/23 04:28

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

10/23 04:24

Enliven Therapeutics | 4：持股变动声明-高管 Kintz Samuel

10/23 04:24

Enliven Therapeutics | 4：持股变动声明-高管 Lyssikatos Joseph P

10/23 04:24

Enliven Therapeutics | 4：持股变动声明-董事 Heyman Richard A.

10/23 04:23

Enliven Therapeutics | 4：持股变动声明-高管 Collins Helen Louise

10/23 04:19

Enliven Therapeutics | 144：拟议出售证券

10/19 06:44